Foot and ankle medical device developer Treace Medical raised $5.9 million in a new round of equity financing, according to an SEC filing posted this week.
Treace Medical is a medical device developer specializing in foot and ankle devices. The company produces the Lapiplasty System, a set of devices designed for a procedure to correct triplanar deformities.
A total of 38 unnamed investors joined in the round, with the 1st date of sale recorded on the May 1, according to the SEC filing.
The Ponte Vedra Beach, Fla.-based company has not yet stated how it plans to spend funds raised in the round.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!